Vaccine: Clinical Trials

50 trials for Vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 10 unknown, 6 recruiting, 2 not yet recruiting. 10 Phase 4, 9 Phase 3, 8 Not applicable, 6 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 410Completed 4, Unknown 3, Recruiting 2, Not yet recruiting 1
Phase 39Completed 7, Unknown 2
Not applicable8Completed 4, Recruiting 2, Unknown 2
Phase 16Completed 3, Recruiting 2, Not yet recruiting 1
Phase 26Completed 5, Not yet recruiting 1
Early Phase 12Active not recruiting 1, Completed 1

Follow Vaccine: new trials by email Literature Review of Vaccine trials Research Report on Vaccine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial
Two-dose M0-M2 vaccination schedule, Two-dose M0-M6 vaccination schedule - Vaccine, Varicella-zoster Virus
Phase 4Not yet recruitingUniversity Hospital, Toulouse1602026-10-202026-09-14
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
Pneumococcal Vaccine - Vaccine, Pneumococcal Disease
Phase 4RecruitingUniversity of Alabama at Birmingham702026-07-012026-08-21
Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor
StrepIncor, Placebo - Rheumatic Heart Disease, Rheumatic Heart Disease in Children
Phase 1 / Phase 2Not yet recruitingUniversity of Sao Paulo General Hospital602025-10-012025-07-22
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
10 ug HDT 321, 25ug HDT-321, 50ug HDT-321 - Vaccine, Crimean-Congo Hemorrhagic Fever
Phase 1RecruitingHDT Bio482025-07-102025-07-28
An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults
Glyconjugate Klebsiella pneumoniae bivalent vaccine - Klebsiella Pneumoniae Infection, Vaccine
Phase 1RecruitingCho Pharma Inc.402025-06-262025-06-27
A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
DC Vaccine - Treatment, Neoantigen
Not applicableRecruitingFudan University92024-11-152026-04-02
PFAS Exposure and Immune Response to Vaccination in Adults
TENIVAC - Innate Inflammatory Response, Vaccination
Phase 4CompletedRutgers, The State University of New Jersey202024-11-042025-12-30
Pneumonia Vaccine Education Intervention Study
Pneumococcal Vaccine Education - Pneumonia, Pneumococcal, Vaccine
Not applicableCompletedGeisinger Clinic1412024-05-062025-07-08
Primary TBE Vaccination for the Elderly
FSME-IMMUN Vaccine - Tick-borne Encephalitis, Vaccine
Phase 4UnknownRegion Örebro County902024-01-012023-11-18
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
REDES, Control - COVID-19, Vaccine
Not applicableRecruitingJohns Hopkins University9002023-07-082025-11-12
The Effect of Shotblocker and Cold Massage on Pain, Crying Time and Physiological Parameters in Babies
Cold Massage Group, ShotBlocker© Group - Vaccine, Pain
Not applicableCompletedOrdu University1082022-11-222025-02-19
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
Inulin, Maltodextrin, Ty21a Typhoid Fever Vaccine - Inflammation, Vaccine
Early Phase 1CompletedUSDA, Western Human Nutrition Research Center602022-09-272025-12-17
Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster
the tested vaccine, the control vaccine - Vaccine
Phase 3CompletedJiangsu Province Centers for Disease Control and Prevention12002022-07-192026-06-29
Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive"
Vaccine for intramuscular injection, Placebo comparator (without active ingredient) for intramuscular injection - Vaccine
Phase 3UnknownChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products3002022-04-012023-03-07
Effects of Shotblocker® and Manual Pressure on Pain
Shotblocker, Manuel Pressure - Healthy Volunteers, Infant
Phase 4CompletedAydin Adnan Menderes University1022022-02-152025-02-07
Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live
Measles, Mumps and Rubella Combined Vaccine, Live - Immunotoxicity, Vaccine
Phase 4CompletedShanghai Institute Of Biological Products10682021-12-232023-08-14
Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)
CMV-MVA Triplex, Placebo - Cytomegalovirus Infections, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)942021-11-022026-10-02
Immunogenicity of COVID-19 Vaccine on Heterologous Schedule
Heterologous prime-boost schedule with AZD1222 and MVC-COV1901, Homologous prime-boost schedule with two doses of AZD1222 - Covid-19, Vaccine
Phase 2CompletedChang Gung Memorial Hospital1002021-09-152026-06-15
Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
Covid-19 vaccine - COVID-19, Vaccine
CompletedUniversità degli Studi dell'Insubria3692021-09-102022-11-02
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma
Prevenar 13 + Pneumovax 23, PREVENAR20 - Vaccine, Streptococcus Pneumoniae
Phase 4RecruitingPoitiers University Hospital1602021-09-072026-05-29

Showing 20 of 50. Sign in to see all of them.

Narrower conditions

COVID-19 (15)  ·  Influenza, Human (7)  ·  Coronavirus Infections (5)  ·  Inflammation (3)  ·  Pain (2)  ·  Typhoid Fever (2)  ·  Behavior (1)  ·  Chickenpox (1)  ·  Cone-Rod Dystrophies (1)  ·  Cytomegalovirus Infections (1)  ·  Diphtheria (1)  ·  Encephalitis, Tick-Borne (1)  ·  HIV Infections (1)  ·  Hemorrhagic Fever, Crimean (1)  ·  Hepatitis B (1)

Broader conditions

Infections (34)  ·  Virus Diseases (28)  ·  RNA Virus Infections (26)  ·  Respiratory Tract Diseases (23)  ·  Respiratory Tract Infections (23)  ·  Lung Diseases (16)  ·  Coronaviridae Infections (15)  ·  Nidovirales Infections (15)  ·  Pneumonia (15)  ·  Pneumonia, Viral (15)  ·  Coronavirus Infections (10)  ·  Orthomyxoviridae Infections (7)  ·  Bacterial Infections (6)  ·  Bacterial Infections and Mycoses (6)  ·  Pathological Conditions, Signs and Symptoms (6)

Interventions

Injections, Intramuscular (2)  ·  Vaccines (2)  ·  13-valent pneumococcal vaccine (1)  ·  23-valent pneumococcal capsular polysaccharide vaccine (1)  ·  AS03 adjuvant (1)  ·  Aspirin (1)  ·  COVID-19 Vaccines (1)  ·  ChAdOx1 nCoV-19 (1)  ·  Diphtheria-Tetanus Vaccine (1)  ·  FSME-IMMUN vaccine (1)  ·  Hepatitis B Vaccines (1)  ·  Inulin (1)  ·  MVC-COV1901 vaccine (1)  ·  Papillomavirus Vaccines (1)  ·  Pneumococcal Vaccines (1)

Sponsors

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products (5)  ·  UMN Pharma Inc. (3)  ·  Beijing 302 Hospital (2)  ·  Jiangsu Province Centers for Disease Control and Prevention (2)  ·  USDA, Western Human Nutrition Research Center (2)  ·  Unity Health Toronto (2)  ·  Aydin Adnan Menderes University (1)  ·  BTG International Inc. (1)  ·  Bangkok Metropolitan Administration Medical College and Vajira Hospital (1)  ·  Chang Gung Memorial Hospital (1)  ·  China National Biotec Group Company Limited (1)  ·  Cho Pharma Inc. (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Fudan University (1)  ·  Geisinger Clinic (1)

Countries

United States (12)  ·  China (7)  ·  Russia (5)  ·  Japan (3)  ·  Taiwan (3)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Indonesia (1)  ·  Italy (1)  ·  Malawi (1)  ·  Malaysia (1)

Top investigators

Danielle Lemay, PhD (2)  ·  Mark H Yudin, MD, MSc (2)  ·  Shu-juan Li, MD (2)  ·  Allison Kempe, MD (1)  ·  Ardis L Olson, MD (1)  ·  Bernie E Medise, MD (1)  ·  Bess Caswell, PhD (1)  ·  Cui Yang, PhD (1)  ·  Darren Wilbraham, MB., BS (1)  ·  David Bernstein, MD (1)  ·  Dongmei Ji, M.D (1)

Results publications

PMID 33306989, PMID 11061799, PMID 16647790, PMID 27836435, PMID 28728074, PMID 31141635, PMID 31348731, PMID 31583123, PMID 31630990, PMID 32702298, PMID 32896291, PMID 33220855, PMID 33288923, PMID 33301246, PMID 33440088, PMID 33510014, PMID 33545094, PMID 33846054, PMID 35711442, PMID 36115850, PMID 36533948, PMID 40132593, PMID 41159533

NIH funding

2025 (1), P30CA023108 (1), R01CA187707 (1), R01MD017364 (1)